Skip to main content

Searle & Co.

SEC CIK
0000710127
Latest filing
Jul 27, 2026

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Searle & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of HZNP by Searle & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−21,350−100.0%Sold outHolders
Q3 202321,350$2.47M0.8%00.0%UnchangedHolders
Q2 202321,350$2.14M0.7%−894−4.0%ReducedHolders
Q1 202322,244$2.47M0.8%−1,106−4.7%ReducedHolders
Q4 202223,350$2.66M0.9%00.0%UnchangedHolders
Q3 202223,350$1.45M0.6%−150−0.6%ReducedHolders
Q2 202223,500$1.87M0.7%+1,000+4.4%AddedHolders
Q1 202222,500$2.37M0.9%00.0%UnchangedHolders
Q4 202122,500$2.42M0.9%00.0%UnchangedHolders
Q3 202122,500$2.46M1.0%00.0%UnchangedHolders
Q2 202122,500$2.11M0.9%00.0%UnchangedHolders
Q1 202122,500$2.07M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.